[1] 陆再英,钟南山.内科学[M].北京:人民卫生出版社,2010:446-452.
[2] 薛晓琳,王天芳,李昕,等.从“肝藏血主疏泄”功能失调角度探讨肝硬化的发生机理.世界中医药,2013,8(2):121-124.
[3] 赵丽红, 王天芳, 薛晓琳, 等. 801例肝炎肝硬化患者常见病性类证候要素在代偿期及失代偿期的分布特点[J]. 北京中医药大学学报, 2015, 38(4): 260-265.
[4] 慕永平,刘成海,张华,等.肝硬化“虚损生积”论——刘平教授学术思想浅析[J].上海中医药大学学报,2013,27(2):1.
[5] 柳诗意.刘燕玲治疗肝病经验[J]中医杂志,2012,53(4):341.
[6] 钱英.“体用同调”是治疗慢重肝的重要一环[C]//中华中医药学会第十二届内科肝胆病学术会议暨第四次国家中医肝病重点专科协作组学术会议专题报告,2006:10.
[7] 李婷婷, 薛晓琳, 王天芳, 等. 中医治疗肝硬化应注重补益肝之阴血思想的初探[J].天津中医药, 2014, 9(31): 8.
[8] Marcelin P,Ziol M,Bedossa P,et al. Non-invasive assessment of liver fibrosis by stiffness measurementin patients with chronic hepatitis B[J].Hepatology,2009,41(1):48-54.
[9] 杨爱婷,白艳锋,尤红. Fibroscan对乙型肝炎肝纤维化诊断的研究进展[J].实用肝脏病杂志,2009,12(2):142-144.
[10] 刘玲峰,陆海英,于岩岩,等. FibroScan检测与超声检查对肝纤维化程度诊断价值的对比分析[J].临床肝胆病杂志,2014,(10):1045-1049.
[11] Arena U,Vizzuti F,Abraldes JG,et al. Reliability of transient elasto graphy for the diagnosis of advanced fibrosis in chro-nic hepatitis C[J].Gut,2008,57( 9): 1288 -1293.
[12] Kim SU,Jang HW,Cheong JY,et al. The usefulness of liver stiffness measurement using FibroScan in chronic hepatitis C in South Korea: a multicenter,prospective study[J]. J Gastroenterol Hepatol,2011,26(1): 171-178.
[13] Chon YE,Choi EH,Song KJ,et al. Performance of transientelastography for the staging of liver fibrosis in patients with chronichepatitis B: a meta-analysis[J].PLoS One,2012,7( 9 ):e44930.
[14] 宣吉晴,李明星,苏松,等. 肝脏瞬时弹性值评估慢性乙型肝炎肝纤维化程度及肝脏储备功能的临床研究[J]. 临床肝胆病杂志,2012,28( 4): 285-288.
[15] Friedrich-Rust M,Müller C,Winckler A,et al. As-sessment of liver fibrosis and steatosis in PBC with FibroScan,MRI,MR-spectroscopy,and serum markers[J]. Journal of Clin Gastroenterol,2012,81(3):325-331.
[16] Ziol M,Handra-Luca A,Kettaneh A,et al. Noninvasiveassessment of liver fibrosis by measurement of stiffness in patientswith chronic hepatitis C[J].Hepatology,2004,36(3): 25-29.
[17] 王一娇,唐少珊. 瞬时弹性成像评价肝纤维化分级的 Meta 分析[J]. 中国医学影像技术,2012,28( 3): 529-533.
[18] 李梵,张健,李永纲,等. FibroScan 检测与慢性肝病临床诊断的相关性研究[J].传染病信息,2010,23(3):136-138.
[19] 李昕,薛晓琳,王天芳,等. 基于临床报道的407例肝炎肝硬化典型病例的治疗方药分析[J].天津中医药,2012,29(6): 600-605.
[20] 李昕,王天芳,薛晓琳,等. 运用复杂网络分析中医药治疗肝炎肝硬化的用药规律[J].中华中医药杂志, 2013,28(5):1495-1499.
[21] 闫雪华.恩替卡韦联合复方鳖甲软肝片治疗代偿期乙肝肝硬化疗效观察[J].西部中医药,2014,27(7):84-86.
[1]陈玉超.中医药治疗晚期胃癌用药与剂型关系[J].环球中医药,2013,6(05):372.
[2]徐庆武 张志威.毛宇湘教授治疗艾滋病临床经验拾粹[J].环球中医药,2013,6(05):374.
[3]李海南 张艳娜 储利荣等.中医药大学开办日本分校的创新实践[J].环球中医药,2014,7(02):140.
[4]方晶 薛博瑜.中医药治疗肝内胆汁淤积的机制研究进展[J].环球中医药,2014,7(03):233.
FANG Jing,XUE Bo yu..Progress on the mechanisms of treating intrahepatic cholestasis with TCM therapy[J].,2014,7(11):233.
[5]马英,姬航宇,甄仲,等.读《重剂起沉疴》小识[J].环球中医药,2013,6(01):44.
[6]莫爵飞,闫秀峰,倪青,等.芪蛭降糖胶囊治疗2型糖尿病早期下肢动脉硬化闭塞症104例[J].环球中医药,2013,6(02):105.
MO Jue fei,YAN Xiu feng,NI Qing..Clinical study on the effect of Qizhi Jiangtang Capsule(a TCM formula) in treating 104 patients with diabetic lower limbs arteriosclerosis obliterans(ASO)[J].,2013,6(11):105.
[7]王学谦,刘杰,林洪生,等.林洪生教授治疗肝内胆管癌术后验案浅析[J].环球中医药,2013,6(03):194.
[8]乐一萍,孙燕妮.中医防治慢性阻塞性肺疾病的机制研究进展[J].环球中医药,2013,6(03):226.
LE Yi ping,SUN Yan ni..The progress of Chinese medicine for prevention and treatment of chronic obstructive pulmonary disease mechanisms[J].,2013,6(11):226.
[9]刘敏,杨蓉,田晶辰,等.航天疾病的中医病机分析[J].环球中医药,2013,6(08):613.
[10]王丽晨,刘慧林,王麟鹏,等.下肢静脉曲张的中医药疗法研究近况[J].环球中医药,2013,6(08):635.
WANG Li chen,LIU Hui lin,WANG Lin peng..Research progress of the traditional Chinese medicine therapy on varicose veins[J].,2013,6(11):635.